Medtronic announces appointment of minimed chief financial officer ahead of intended separation into standalone company

Galway, ireland , july 8, 2025 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced the appointment of chad spooner as chief financial officer (cfo) of minimed, in advance of its intended separation into a standalone, public company. effective july 14, 2025, chad will be responsible for overseeing the finance function for medtronic diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.
MDT Ratings Summary
MDT Quant Ranking